We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterisation of People With COPD (CoCO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01263340
Recruitment Status : Completed
First Posted : December 20, 2010
Last Update Posted : December 5, 2013
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
National Services for Health Improvement Ltd

Brief Summary:
The investigators will describe the characteristics, prevalence, incidence, severity co-morbidity and management of patients with chronic obstructive pulmonary disease (COPD) in the UK. 100 practices will be sampled amounting to a total study population of about 10 000 patients. Information will be collected electronically and, where necessary, by a hand search of patient records.

Condition or disease
Chronic Obstructive Pulmonary Disease

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 10000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Observational, Multi-centre, Retrospective Cohort Study to Evaluate Prevalence, Incidence, Severity, Co-morbidities and Burden of Disease in Patients With a Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) by Close Scrutiny of the Patient Journey
Study Start Date : December 2010
Primary Completion Date : April 2013
Study Completion Date : April 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD Lung Diseases
U.S. FDA Resources

Group/Cohort
People with COPD



Primary Outcome Measures :
  1. Prevalence and characterisation of people with COPD [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People with a Read code diagnosis of COPD
Criteria

Inclusion Criteria:

  • people with a read code diagnosis of COPD

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01263340


Locations
United Kingdom
NHS primary care centres
Nationwide, United Kingdom
Sponsors and Collaborators
National Services for Health Improvement Ltd
GlaxoSmithKline
Investigators
Principal Investigator: John Haughney, FRCPE FRCGP NSHI Ltd

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: National Services for Health Improvement Ltd
ClinicalTrials.gov Identifier: NCT01263340     History of Changes
Other Study ID Numbers: SCO115217
First Posted: December 20, 2010    Key Record Dates
Last Update Posted: December 5, 2013
Last Verified: December 2013

Keywords provided by National Services for Health Improvement Ltd:
COPD
observational study
prevalence
characterisation

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases